{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:28:38Z","timestamp":1786512518983,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pathological grade and muscular invasion determine bladder cancer treatment and prognosis. Conventional CT lacks quantitative tumor characterization, while gemstone spectral imaging CT (GSI-CT) provides perfusion-related quantitative metrics; systemic inflammatory markers also correlate with tumor aggressiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore whether combined GSI-CT parameters and inflammatory markers improve preoperative bladder cancer grading, and analyze their association with muscular invasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective study enrolled 61 pathologically confirmed bladder cancer patients (26 low-grade, 35 high-grade) with preoperative GSI-CT. Venous-phase iodine concentration (IC), spectral slope \u03bbHU, effective atomic number (Zeff) and four inflammatory indices were measured. Between-group comparisons, logistic regression and DeLong ROC comparison were performed using SPSS 25.0 and R 4.3.3 (\u03b1 = 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Venous-phase IC, \u03bbHU and Zeff were significantly elevated in high-grade lesions, while lymphocyte-to-monocyte ratio (LMR) was markedly lower (all\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). The \u03bbHU + LMR combined model yielded an AUC of 0.877 versus LMR alone (AUC = 0.835), with no statistically significant diagnostic improvement (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.061) by DeLong test. After adjusting for tumor diameter, both \u03bbHU and LMR remained independent grading predictors. A\n                      <jats:italic>post-hoc<\/jats:italic>\n                      inflammation-free subgroup analysis suggested \u03bbHU may partially offset the confounding effect of systemic inflammation on LMR performance, though this result is exploratory and requires further validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined GSI-CT and LMR jointly reflect tumor angiogenesis and host immunity, yet the dual-parameter model offered no statistically meaningful incremental grading value over LMR in this NMIBC-dominated single-center cohort. The auxiliary value of \u03bbHU needs large multi-center prospective verification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1892226","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:47:23Z","timestamp":1786510043000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Spectral CT-derived quantitative imaging parameters combined with inflammatory markers for exploratory preoperative grading of bladder cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Shuang","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Shanghai Xuhui Central Hospital\/Xuhui Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Tongji Hospital Affiliated to Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Xuhui Central Hospital\/Xuhui Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Shanghai Xuhui Central Hospital\/Xuhui Hospital, Fudan University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3322\/caac.21830","article-title":"Erratum to \"Cancer statistics, 2024\"","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.018","article-title":"Corrigendum to \"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines\"","volume":"85","author":"Witjes","year":"2024","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non\u2013muscle-invasive Bladder Cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle\u2010invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.04.008","article-title":"Contemporary staging for muscle-invasive bladder cancer: accuracy and limitations","volume":"5","author":"Hensley","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2008.09.017","article-title":"Evaluation of non-linear blending in dual-energy computed tomography","volume":"68","author":"Holmes","year":"2008","journal-title":"Eur J Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2522080557","article-title":"Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images","volume":"252","author":"Graser","year":"2009","journal-title":"Radiology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-024-01881-8","article-title":"Diagnostic value of dual-layer spectral detector CT parameters for differentiating high- from low-grade bladder cancer","volume":"16","author":"Chen","year":"2025","journal-title":"Insights Imaging"},{"key":"B12","article-title":"Iodine quantitative analysis technology of single-source dual-energy CT:value of differential diagnosis for urothelial carcinoma of bladder with different pathological grades","volume-title":"Radiol Pract","author":"Yang","year":"2019"},{"key":"B13","article-title":"The application value of gemstone spectral CT in preoperative staging of bladder carcinoma","volume-title":"J Med Imaging","author":"Yu","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-021-01195-5","article-title":"Usefulness of advanced monoenergetic reconstruction technique in dual-energy computed tomography for detecting bladder cancer","volume":"40","author":"Nakagawa","year":"2022","journal-title":"Jpn J Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664392","article-title":"Association between the pretreatment albumin-to-alkaline phosphatase ratio and clinical outcomes in patients with bladder cancer treated with radical cystectomy: a retrospective cohort study","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.04.026","article-title":"Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy","volume":"39","author":"Claps","year":"2021","journal-title":"Urol Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23684","article-title":"Prediction of lymph node metastasis in oral tongue squamous cell carcinoma using the neutrophil-to-lymphocyte ratio and platelet-to-neutrophil ratio","volume":"35","author":"Wang","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-026-02275-8","article-title":"Assessment of multi-parameter dual-energy CT in predicting muscle invasion in bladder cancer: comparison with VI-RADS","volume":"17","author":"Sun","year":"2026","journal-title":"Insights into Imaging"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2018.06.006","article-title":"Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer","volume":"1","author":"Cantiello","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04683-0","article-title":"Spectral CT for non-invasive evaluation of bladder cancer grade","volume":"50","author":"Trimarchi","year":"2025","journal-title":"Abdom Radiol (NY)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.19300\/j.2019.L7305","article-title":"The value of spectral curve in the differential diagnosis of urothelial carcinoma of the bladder with different pathological grades","volume":"42","author":"Yang","year":"2019","journal-title":"International journal of medical radiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines","volume":"85","author":"Witjes","year":"2024","journal-title":"Eur Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16131948","article-title":"Diagnostic and Prognostic Non-Invasive Markers in Bladder Cancer","volume":"16","author":"Sim","year":"2026","journal-title":"Diagnostics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.365","article-title":"Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review","volume":"5","author":"Klempfner","year":"2024","journal-title":"BJUI Compass"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.04.008","article-title":"Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations","volume":"5","author":"Hensley","year":"2022","journal-title":"European Urology Oncology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/tomography10030024","article-title":"Dual-Energy CT in Oncologic Imaging","volume":"10","author":"Foti","year":"2024","journal-title":"Tomography"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/reports8030186","article-title":"Dual-layer spectral CT for advanced tissue characterization: differentiating bladder neoplasm from intraluminal thrombus\u2014a case report","volume":"8","author":"Catalano","year":"2025","journal-title":"Reports"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005705","article-title":"Application of dual-energy spectral CT imaging in differential diagnosis of bladder cancer and benign prostate hyperplasia Medicine","volume":"95","author":"Liu","year":"2016"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1053\/j.sult.2023.03.001","article-title":"The Role of Dual-Energy CT in the Study of Urinary Tract Tumors: Review of Recent Literature","volume":"44","author":"Galluzzo","year":"2023","journal-title":"Seminars in Ultrasound, CT and MRI"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1601040","article-title":"Prognostic value of lymphocyte to monocyte ratio for the patients with bladder cancer: a systematic review and meta-analysis","volume":"15","author":"Ren","year":"2025","journal-title":"Frontiers in Oncology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15103856","article-title":"Advancing genitourinary cancer surgery: the role of artificial intelligence and robotics","volume":"15","author":"Katsimperis","year":"2026","journal-title":"J Clin Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1892226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:47:33Z","timestamp":1786510053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1892226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":33,"alternative-id":["10.3389\/fonc.2026.1892226"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1892226","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1892226"}}